Ultragenyx Pharmaceutical (NASDAQ:RARE) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The firm currently has a $115.00 target price on the biopharmaceutical company’s stock. RARE has been the topic of a number of other research reports. Stifel Nicolaus increased […]
More Stories
iExec RLC (RLC) Hits Market Capitalization of $111.47 Million
iExec RLC (RLC) traded up 4.8% against the dollar during the 1-day period ending at 20:00 PM ET on October...
UMA (UMA) Market Cap Hits $243.90 Million
UMA (UMA) traded 3.6% lower against the U.S. dollar during the one day period ending at 20:00 PM ET on...
NuCypher (NU) Trading Up 0.4% Over Last Week
NuCypher (NU) traded 0.8% lower against the dollar during the one day period ending at 20:00 PM Eastern on October...
NULS (NULS) 24 Hour Volume Hits $1.02 Million
NULS (NULS) traded 3.1% higher against the U.S. dollar during the twenty-four hour period ending at 20:00 PM Eastern on...
Decentraland (MANA) Price Up 15.2% This Week
Decentraland (MANA) traded 15.2% higher against the dollar during the 1 day period ending at 20:00 PM E.T. on October...
Lido DAO (LDO) Trading 5.4% Higher This Week
Lido DAO (LDO) traded 4.1% higher against the dollar during the twenty-four hour period ending at 20:00 PM E.T. on...